ACUTA CAPITAL PARTNERS, LLC

13F Filings History

Latest 13F report
Q3 2024 - Nov 14, 2024
Value $
$123M
Signature - Title
Scott Smith - Chief Operating Officer
Location
Redwood City, CA
Summary
This page shows a list of all the recent 13F filings made by ACUTA CAPITAL PARTNERS, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. ACUTA CAPITAL PARTNERS, LLC reported 41 stock holdings with total value $123M as of Q3 2024. Top holdings included PCVX, OCUL, TRML, INSM, and ELVN.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 41 $123M +$31.1M -$45.5M -$14.4M PCVX, OCUL, TRML, INSM, ELVN 13F-HR 11/14/2024, 07:06 AM
Q2 2024 32 $119M +$19.1M -$39.6M -$20.5M OCUL, ELVN, PCVX, DYN, PRAX 13F-HR 8/14/2024, 09:16 AM
Q1 2024 33 $154M +$30.2M -$93.7M -$63.5M OCUL, PRAX, MRSN, TSHA, RCKT 13F-HR 5/15/2024, 07:56 AM
Q4 2023 38 $178M +$56.7M -$50.8M +$5.93M RYZB, CBAY, RCKT, KURA, EYPT 13F-HR 2/14/2024, 10:29 AM
Q3 2023 42 $138M +$42.1M -$27.9M +$14.2M TSHA, APLS, AADI, PRAX, RYZB 13F-HR 11/14/2023, 09:16 AM
Q2 2023 35 $148M +$39.3M -$33.7M +$5.66M APLS, AADI, TERN, KURA, SNDX 13F-HR 8/14/2023, 07:49 AM
Q1 2023 33 $128M +$12.4M -$34.6M -$22.3M APLS, AADI, TERN, CBAY, VTYX 13F-HR 5/15/2023, 07:26 AM
Q4 2022 34 $155M +$42.6M -$100M -$57.5M AADI, VRDN, APLS, TERN, UTHR 13F-HR 2/14/2023, 04:08 PM
Q3 2022 46 $225M +$48.2M -$35.6M +$12.5M APLS, AADI, BLU, RLMD, ISEE 13F-HR 11/14/2022, 10:24 AM
Q2 2022 41 $179M +$30.9M -$24.9M +$6.05M APLS, AADI, VTGN, KURA, BLSA 13F-HR 8/15/2022, 06:10 PM
Q1 2022 38 $210M +$34.9M -$30.1M +$4.88M APLS, AADI, VTGN, CLDX, RLMD 13F-HR 5/16/2022, 08:37 AM
Q4 2021 36 $238M +$64.2M -$87.7M -$23.5M AADI, APLS, VTGN, CLDX, GHRS 13F-HR 2/14/2022, 08:12 AM
Q3 2021 46 $281M +$100M -$79.4M +$20.8M AADI, VTGN, ISEE, CLDX, BLU 13F-HR 11/15/2021, 02:24 PM
Q2 2021 37 $234M +$29.7M -$85.6M -$55.9M VTGN, CLDX, APLS, ARWR, BLSA 13F-HR 8/16/2021, 12:05 PM
Q1 2021 46 $277M +$82.4M -$139M -$56.8M VTGN, CLDX, KURA, AVDL, ISEE 13F-HR 5/17/2021, 11:27 AM
Q4 2020 50 $363M +$93.3M -$126M -$33.2M CLDX, SAGE, KURA, LRMR, MRSN 13F-HR 2/16/2021, 06:04 AM
Q3 2020 42 $340M +$130M -$174M -$44M IMMU, KURA, CLDX, SAGE, CMPS 13F-HR 11/16/2020, 12:17 PM
Q2 2020 46 $346M +$151M -$75.6M +$75.1M ADVM, IMMU, BTAI, IOVA, MRSN 13F-HR 8/14/2020, 04:22 PM
Q1 2020 32 $206M +$61.8M -$139M -$76.7M AVDL, AXSM, ADVM, IOVA, ARVN 13F-HR 5/15/2020, 04:11 PM
Q4 2019 35 $352M +$152M -$42.5M +$109M AXSM, ARWR, KDMN, AUPH, ITCI 13F-HR 2/14/2020, 10:50 AM
Q3 2019 30 $127M +$24.9M -$121M -$96.3M KDMN, IOVA, ARVN, ARWR, AXSM 13F-HR 11/13/2019, 09:15 PM
Q2 2019 27 $259M +$82M -$73M +$8.96M IOVA, KDMN, ADVM, VCYT, ARWR 13F-HR 8/14/2019, 03:36 PM
Q1 2019 31 $208M +$75M -$11.4M +$63.5M IOVA, KDMN, ASMB, CASM, INSM 13F-HR 5/13/2019, 09:46 PM
Q4 2018 18 $116M +$16.9M -$91.3M -$74.4M IOVA, ASMB, KDMN, CASM, BHVN 13F-HR 2/14/2019, 10:22 AM
Q3 2018 23 $250M +$6.21M -$244M -$238M IMMU, ASMB, IOVA, KDMN, CEMI 13F-HR 11/6/2018, 09:11 PM
Q2 2018 37 $507M +$96.9M -$105M -$8.55M IMMU, IOVA, ASMB, ARGX, KDMN 13F-HR 8/14/2018, 09:12 PM
Q1 2018 30 $477M +$82.2M -$58.6M +$23.6M IMMU, IOVA, ASMB, ASND, ARGX 13F-HR 5/15/2018, 06:13 AM
Q4 2017 31 $403M +$52.9M -$38.1M +$14.8M IMMU, ASMB, IOVA, VCYT, ASND 13F-HR 2/13/2018, 09:24 PM
Q3 2017 35 $371M +$150M -$58M +$91.8M IMMU, ASMB, VCYT, IOVA, IRIX 13F-HR 11/14/2017, 04:40 PM
Q2 2017 35 $245M +$86.2M -$104M -$17.7M ASND, VCYT, IOVA, ASMB, IRIX 13F-HR 8/11/2017, 06:07 PM
Q1 2017 41 $277M +$73.9M -$95.9M -$22M VCYT, ASMB, LBIO, IRIX, ACAD 13F-HR 5/15/2017, 06:20 AM
Q4 2016 38 $251M +$71.4M -$64.1M +$7.24M VCYT, LBIO, IRIX, IMMU, EDGE 13F-HR 2/13/2017, 04:26 PM
Q3 2016 53 $243M +$66.3M -$55.5M +$10.9M LBIO, VCYT, IRIX, IMMU, EVDY 13F-HR 11/15/2016, 06:04 AM
Q2 2016 56 $199M +$69.5M -$45.6M +$23.9M LBIO, VCYT, IRIX, IMMU, RRM 13F-HR 8/15/2016, 02:09 PM
Q1 2016 36 $173M +$64.4M -$52M +$12.4M FOLD, VCYT, IMMU, LBIO, ASND 13F-HR 5/13/2016, 05:05 PM
Q4 2015 47 $188M +$85.3M -$53.2M +$32M OLED, LBIO, FOLD, VCYT, IMMU 13F-HR 2/12/2016, 04:53 PM
Q3 2015 52 $158M +$65.6M -$39.2M +$26.5M FOLD, EXEL, ASND, LBIO, BEAT 13F-HR 11/16/2015, 04:43 PM
Q2 2015 49 $153M +$75.1M -$37.1M +$38M FOLD, AGTC, VCYT, LBIO, ASND 13F-HR 8/14/2015, 06:08 AM
Q1 2015 46 $112M +$46.5M -$44.6M +$1.87M FOLD, LBIO, CEMP, ALIM, BEAT 13F-HR 5/14/2015, 05:49 PM
Q4 2014 54 $101M $0 $0 FOLD, ALIM, PTX, BEAT, LMAT 13F-HR 2/12/2015, 05:54 PM